EE03612B1 - Asendatud tetratsüklilised tetrahüdrofuraanderivaadid - Google Patents

Asendatud tetratsüklilised tetrahüdrofuraanderivaadid

Info

Publication number
EE03612B1
EE03612B1 EE9800326A EE9800326A EE03612B1 EE 03612 B1 EE03612 B1 EE 03612B1 EE 9800326 A EE9800326 A EE 9800326A EE 9800326 A EE9800326 A EE 9800326A EE 03612 B1 EE03612 B1 EE 03612B1
Authority
EE
Estonia
Prior art keywords
6alkyl
pct
zero
independently
optionally substituted
Prior art date
Application number
EE9800326A
Other languages
English (en)
Other versions
EE9800326A (et
Inventor
Javier Fernndez-Gadea Francisco
Franz Meert Theo
Gil-Lopetegui Pilar
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8223868&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE03612(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE9800326A publication Critical patent/EE9800326A/et
Publication of EE03612B1 publication Critical patent/EE03612B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Addiction (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EE9800326A 1996-04-12 1997-04-09 Asendatud tetratsüklilised tetrahüdrofuraanderivaadid EE03612B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96200990 1996-04-12
PCT/EP1997/001829 WO1997038991A1 (en) 1996-04-12 1997-04-09 Substituted tetracyclic tetrahydrofuran derivatives

Publications (2)

Publication Number Publication Date
EE9800326A EE9800326A (et) 1999-04-15
EE03612B1 true EE03612B1 (et) 2002-02-15

Family

ID=8223868

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800326A EE03612B1 (et) 1996-04-12 1997-04-09 Asendatud tetratsüklilised tetrahüdrofuraanderivaadid

Country Status (30)

Country Link
US (3) US6057441A (et)
EP (1) EP0892793B1 (et)
JP (1) JP3199751B2 (et)
KR (1) KR100389298B1 (et)
CN (1) CN1116291C (et)
AT (1) ATE236893T1 (et)
BG (1) BG63083B1 (et)
BR (1) BR9706639A (et)
CA (1) CA2232141C (et)
CY (1) CY2382B1 (et)
CZ (1) CZ288865B6 (et)
DE (1) DE69720709T2 (et)
DK (1) DK0892793T3 (et)
EA (1) EA001002B1 (et)
EE (1) EE03612B1 (et)
ES (1) ES2196328T3 (et)
HK (1) HK1015771A1 (et)
HU (1) HUP9901613A3 (et)
IL (1) IL123655A (et)
MY (1) MY119321A (et)
NO (1) NO317156B1 (et)
NZ (1) NZ329953A (et)
PL (1) PL190960B1 (et)
PT (1) PT892793E (et)
SI (1) SI0892793T1 (et)
SK (1) SK283400B6 (et)
TR (1) TR199801164T2 (et)
TW (1) TW504506B (et)
WO (1) WO1997038991A1 (et)
ZA (1) ZA973114B (et)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA001002B1 (ru) * 1996-04-12 2000-08-28 Жансен Фармасетика Н.В. Замещенные тетрациклические производные тетрагидрофурана
UA52778C2 (uk) 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
US20050148018A1 (en) 1999-10-07 2005-07-07 David Weiner Methods of identifying inverse agonists of the serotonin 2A receptor
HRP20000310A2 (en) * 2000-05-17 2002-02-28 Pliva Farmaceutska Ind Dioniko New dibenzoazulene compounds as tumor necrosis factor inhibitors
WO2002056873A2 (en) * 2000-12-22 2002-07-25 Bayer Pharmaceuticals Corporation 2-substituted dibenzo[a,e]1,2,3-triazolo[4,5-c][7]annulen-8-ones as growth hormone secretagogues
UA79248C2 (en) * 2001-11-09 2007-06-11 Janssen Pharmaceutica Nv Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
JP4516752B2 (ja) 2001-12-07 2010-08-04 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ トランス−縮合３，３ａ，８，１２ｂ−テトラヒドロ−２Ｈ−ジベンゾ［３，４：６，７］シクロヘプタ［１，２−ｂ］フラン誘導体の製造法
AU2002352205A1 (en) 2001-12-07 2003-06-17 Janssen Pharmaceutica N.V. Preparation of cis-fused 3,3a,8,12b-tetrahydro-2H-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives
HRP20020305A8 (en) 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20030160A2 (en) * 2003-03-06 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. 1-thiadibenzoazulene derivatives and biological action thereof
HRP20030885A2 (en) * 2003-11-03 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS
HRP20030957A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1-THIA-3-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030958A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1,3-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030956A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANU
HRP20030954A2 (en) * 2003-11-21 2005-08-31 Pliva D.D. USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030955A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030953A2 (en) * 2003-11-21 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. PREPARATION OF 1-AZA-2-OXA-DIBENZO[e,h]AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20040104A2 (en) * 2004-01-30 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
CN1968942B (zh) * 2004-06-14 2011-06-15 詹森药业有限公司 四环四氢呋喃衍生物
US8022102B2 (en) 2004-06-23 2011-09-20 Janssen Pharmaceutica, Nv Unsaturated tetracyclic tetrahydrofuran derivatives
AU2011202995B2 (en) * 2004-12-07 2012-02-02 Janssen Pharmaceutica N.V. Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
WO2006061392A2 (en) 2004-12-07 2006-06-15 Janssen Pharmaceutica N.V. Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
BRPI0607088A2 (pt) * 2005-01-27 2009-08-04 Janssen Pharmaceutica Nv derivados de tetrahidrofurano heterocìclico tetracìclico como inibidores de 5ht2 no tratamento de distúrbios cns
KR20080015407A (ko) * 2005-05-19 2008-02-19 얀센 파마슈티카 엔.브이. 사이클릭 아민 측쇄를 함유한 선택된 테트라사이클릭테트라하이드로푸란 유도체
MX2007014857A (es) * 2005-05-26 2008-02-14 Janssen Pharmaceutica Nv Derivados de tetrahidrofurano, pirrolidina y tetrahidrotiofeno tetraciclicos, sustituidos, novedosos y su uso como un medicamento.
WO2006134163A2 (en) * 2005-06-17 2006-12-21 Janssen Pharmaceutica N.V. Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605526A (nl) * 1976-05-24 1977-11-28 Akzo Nv Nieuwe tetracyclische derivaten.
DE2742794A1 (de) * 1976-11-15 1978-05-18 Dec Int Vorrichtung zur befoerderung von gemahlenem kaese
EP0361791B1 (en) * 1988-09-26 1995-11-08 Smithkline Beecham Farmaceutici S.p.A. Azacyclic derivatives useful as medicaments
MY110227A (en) * 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
FR2681320B1 (fr) * 1991-09-12 1994-01-14 Synthelabo Derives de n-(4,7dimethoxyindan-2-yl)-1-(phenylcarbonyl)-n-propyl-piperidine-4-methanamine, leur preparation et leur application en therapeutique.
FR2681325B1 (fr) * 1991-09-16 1993-12-17 Fabre Medicament Pierre Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
AU7129596A (en) * 1995-09-15 1997-04-01 Neurosearch A/S Piperidine compounds as calcium channel blockers
EA001002B1 (ru) * 1996-04-12 2000-08-28 Жансен Фармасетика Н.В. Замещенные тетрациклические производные тетрагидрофурана

Also Published As

Publication number Publication date
MY119321A (en) 2005-05-31
CN1205006A (zh) 1999-01-13
CY2382B1 (en) 2004-06-04
EA001002B1 (ru) 2000-08-28
PL190960B1 (pl) 2006-02-28
AU712154B2 (en) 1999-10-28
HUP9901613A3 (en) 2001-08-28
US6194405B1 (en) 2001-02-27
CZ324398A3 (cs) 1999-01-13
BR9706639A (pt) 1999-01-12
AU2695997A (en) 1997-11-07
HUP9901613A2 (hu) 1999-09-28
BG63083B1 (bg) 2001-03-30
DE69720709T2 (de) 2004-03-11
IL123655A (en) 2001-03-19
EE9800326A (et) 1999-04-15
NO981076L (no) 1998-10-09
JP3199751B2 (ja) 2001-08-20
KR100389298B1 (ko) 2003-10-30
IL123655A0 (en) 1998-10-30
EP0892793B1 (en) 2003-04-09
SK141898A3 (en) 1999-03-12
BG102820A (en) 1999-08-31
TW504506B (en) 2002-10-01
TR199801164T2 (xx) 1998-10-21
EP0892793A1 (en) 1999-01-27
ES2196328T3 (es) 2003-12-16
NO981076D0 (no) 1998-03-11
US6057441A (en) 2000-05-02
CA2232141A1 (en) 1997-10-23
US6288058B1 (en) 2001-09-11
ATE236893T1 (de) 2003-04-15
CZ288865B6 (cs) 2001-09-12
CN1116291C (zh) 2003-07-30
PL328575A1 (en) 1999-02-01
SI0892793T1 (en) 2003-10-31
CA2232141C (en) 2006-05-23
KR19990067514A (ko) 1999-08-25
EA199800348A1 (ru) 1998-10-29
NZ329953A (en) 1999-06-29
JP2000508327A (ja) 2000-07-04
HK1015771A1 (en) 1999-10-22
ZA973114B (en) 1998-10-12
PT892793E (pt) 2003-08-29
DE69720709D1 (de) 2003-05-15
DK0892793T3 (da) 2003-07-21
WO1997038991A1 (en) 1997-10-23
NO317156B1 (no) 2004-08-30
SK283400B6 (sk) 2003-07-01

Similar Documents

Publication Publication Date Title
DK0892793T3 (da) Substituerede tetracykliske tetrahydrofuranderivater
CA2305612A1 (en) Halogen substituted tetracyclic tetrahydrofuran derivatives
TW333532B (en) Benzopyrans
NZ329954A (en) Isoxazolidine tetracyclic and tricyclic ring system derivatives and medicaments
MY113325A (en) Substituted tetracyclic azepine derivatives
SE9701396D0 (sv) Compounds
PL319870A1 (en) Derivatives of tetracyclic substituted oxazepin and thiazepin exhibiting affinity in respect to 5-ht2 receptors
CA2232195A1 (en) Isoxazolidine derivatives
MX9703250A (es) Derivados tetraciclicos de oxazepina y tiazepina sustituidos con afinidad al receptor de 5-ht2.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

MM4A Lapsed by not paying the annual fees

Effective date: 20080409